Jublia is a medicine used to treat fungal infections of the toenails. It is a liquid you brush onto the nail once a day, usually for about a year. It works by stopping the fungus from building its cell walls so it can't keep growing.
Every report comes from a Lived member, sent anonymously.
Have you tried Jublia (Efinaconazole) for Nail Fungus?
Efinaconazole, sold as Jublia, is a prescription antifungal liquid that is brushed onto the toenail to treat toenail fungus (onychomycosis). This common infection can make a nail thick, discolored, crumbly or split, and it can be uncomfortable in shoes. Jublia is approved for toenail infections caused by the two fungi responsible for most cases, in people 6 and older. It is not approved for fingernails. It is one of a few medicines applied directly to the nail. Clinicians often consider it for mild to moderate infections, or when someone would rather avoid antifungal pills such as terbinafine, which work throughout the body and need liver blood tests. Because other nail problems, including psoriasis and injury, can look like fungus, a clinician may test a nail sample first to confirm the diagnosis.
Fungi need a substance called ergosterol to build their cell membranes, much as human cells use cholesterol. Efinaconazole belongs to the azole family of antifungals and blocks an enzyme the fungus uses to make ergosterol. Without it, the fungus cannot keep growing. Because the fungus lives in and under the nail, the solution is applied over the nail, its edges and the skin beneath it. Treatment stops the infection from advancing, but the damaged part of the nail does not repair itself. It has to be replaced by healthy nail growing out from the base, which is why treatment takes so long.
Jublia comes as a 10% solution in a bottle with a built-in brush. It is applied once a day for 48 weeks. Each application should cover the whole affected nail, the skin folds along its sides, and the skin and nail edge underneath the tip. Apply it to clean, dry nails, and wait at least 10 minutes after a shower, bath or foot wash before applying. Use it only on the toenails your clinician has identified and the skin right around them. It is not for the mouth, eyes or vagina. Whether nail polish or other cosmetic nail products affect how well it works has not been studied, so ask before using them during treatment. Daily use for the full course matters more than any single dose, and stopping early when the nail starts to look better is a common reason treatment falls short.
In the main trials, side effects were uncommon (each affected about 1% to 2% of people) and were at the treated toe: irritation or a rash on the surrounding skin, small blisters, pain where it is applied, and ingrown toenails. Redness and peeling of the skin, a change in nail color, and the nail loosening from its bed have also been reported. Let your clinician know if redness, itching or swelling around the nail persists, since it may need a change in treatment.
The solution is flammable. Keep the bottle and freshly treated nails away from heat and open flame, including lit cigarettes. Unlike antifungal pills such as itraconazole and terbinafine, which can interact with many medicines and require liver monitoring, Jublia is not expected to cause meaningful drug interactions. Lab studies show it does not affect the liver enzymes that process most medicines. There are no human data on using it during pregnancy, and it is not known whether it passes into breast milk. Animal studies did not show harm to a developing fetus at exposures far above normal use. Because toenail fungus is rarely urgent, people who are pregnant, planning pregnancy or breastfeeding should discuss with their clinician whether to treat now or wait.
Progress is slow. Toenails grow out over 12 to 18 months, so the nail often still looks abnormal at the end of the 48 weeks even when the fungus is gone. Improvement shows up as clear, healthy nail growing out from the base. Results are real but modest. In the two main trials, in adults with 20% to 50% of a toenail affected, about 15% to 18% of people using Jublia had a fully clear nail with no fungus on lab tests at one year, compared with about 3% to 6% with an inactive solution. More than half had the fungus cleared on lab tests even when the nail did not look completely normal. Results may be less favorable when the infection reaches the base of the nail, where it grows from, or covers most of the nail, since those cases were not studied. Nail fungus can come back, sometimes a year or more after it clears. Because the risk of another infection stays higher afterward, a clinician may suggest continuing a nail treatment as prevention once it clears, especially for people with diabetes, poor circulation in the legs or a nail injury.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Jublia (Efinaconazole), what you've noticed, or ask the community a question.